Bumper Offer - Urjas oil Just @ Rs. 1
Sucramore is a prescription medicine that is available as a Suspension. Primarily, it is used for the treatment of Peptic Ulcer. Other than this, Sucramore has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Sucramore depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Sucramore include Constipation. Apart from the aforementioned side effects, Sucramore can also lead to other problems, which have been listed below. Normally, these side effects of Sucramore are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Sucramore's effect during pregnancy is Unknown and Unknown while nursing. In addition, Sucramore's effects on the liver, heart and kidney are discussed below in the Sucramore related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Sucramore since this can cause severe adverse effects. Some other conditions that can be affected by Sucramore are listed in the contraindications section below.
Additionally, Sucramore may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Sucramore is not safe while driving, and is is not addictive in nature.
Sucramore is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Sucramore is used -
Moderate
Mild
Common
Is the use of Sucramore safe for pregnant women?
No research has been done to ascertain the safety of Sucramore in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Sucramore safe during breastfeeding?
In the absence of any scientific study about the side effects of Sucramore in breastfeeding women, information on safety of Sucramore is unavailable.
What is the effect of Sucramore on the Kidneys?
Sucramore rarely affects the kidneys.
What is the effect of Sucramore on the Liver?
Sucramore is completely safe for the liver.
What is the effect of Sucramore on the Heart?
Sucramore is not harmful for the heart.
Sucramore should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Sucramore unless your doctor advises you to do so -
Is this Sucramore habit forming or addictive?
Forming a habit of Sucramore has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Sucramore. So it is best to avoid driving.
Is it safe?
Yes, Sucramore is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Sucramore is not used to treat mental disorders.
Interaction between Food and Sucramore
It is safe to take Sucramore with food.
Interaction between Alcohol and Sucramore
It is difficult to say anything about the effect of Sucramore and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Carafate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 656-657
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1154-1155
